Yan Huang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Acute Myeloid Leukemia

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Journal of translational medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer innovation

This page only lists publications with an associated author ORCID identifier.

Publications

Bijing Xiao, Guanjun Li, Haimiti Gulizeba, Hong Liu, Xiaoxian Sima, Ting Zhou, Yan Huang
Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferation. Journal of translational medicine 22 (1) (2024)
Shaoxing Guan, Xi Chen, Yuru Wei, Fei Wang, Wen Xie, Youhao Chen, Heng Liang, Xia Zhu, Yunpeng Yang, Wenfeng Fang, Yan Huang, Hongyun Zhao, Xiao-Xu Zhang, Shu Liu, Wei Zhuang, Min Huang, Xue-Ding Wang, Li Zhang
Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Bijing Xiao, Guanjun Li, Haimiti Gulizeba, Hong Liu, Xiaoxian Sima, Ting Zhou, Yan Huang
Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferation. Journal of translational medicine 22 (1) (2024)
Shaoxing Guan, Xi Chen, Yuru Wei, Fei Wang, Wen Xie, Youhao Chen, Heng Liang, Xia Zhu, Yunpeng Yang, Wenfeng Fang, Yan Huang, Hongyun Zhao, Xiao-Xu Zhang, Shu Liu, Wei Zhuang, Min Huang, Xue-Ding Wang, Li Zhang
Germline USP36 mutation confers resistance to EGFR-TKIs by upregulating MLLT3 expression in non-small cell lung cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Hong Liu, Xiaoxian Sima, Bijing Xiao, Haimiti Gulizeba, Shen Zhao, Ting Zhou, Yan Huang
Integrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cell-related regulon predicting neoadjuvant immunotherapy response across cancers. Journal of translational medicine 22 (1) (2024)
Shaoxing Guan, Xi Chen, Yuru Wei, Fei Wang, Wen Xie, Youhao Chen, Heng Liang, Xia Zhu, Yunpeng Yang, Wenfeng Fang, Yan Huang, Hongyun Zhao, Xiao-Xu Zhang, Shu Liu, Wei Zhuang, Min Huang, Xue-Ding Wang, Li Zhang
Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Bijing Xiao, Guanjun Li, Haimiti Gulizeba, Hong Liu, Xiaoxian Sima, Ting Zhou, Yan Huang
Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferation. Journal of translational medicine 22 (1) (2024)
Hong Liu, Xiaoxian Sima, Bijing Xiao, Haimiti Gulizeba, Shen Zhao, Ting Zhou, Yan Huang
Integrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cell-related regulon predicting neoadjuvant immunotherapy response across cancers. Journal of translational medicine 22 (1) (2024)
Hong Liu, Xiaoxian Sima, Bijing Xiao, Haimiti Gulizeba, Shen Zhao, Ting Zhou, Yan Huang
Integrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cell-related regulon predicting neoadjuvant immunotherapy response across cancers. Journal of translational medicine 22 (1) (2024)
Yan Huang, Li Zhang
Annual progress of clinical research on targeted therapy for nonsmall cell lung cancer in 2022. Cancer innovation 2 (1) (2023)